3-BETA-ACETOXY-16-BETA-(5-ACETYL-1H-TETRAZOL-1-YLMETHYL)-ANDROST-5-EN-17-BETA-OL
Compound with spectra: 1 NMR
| SpectraBase Compound ID | 5Sna9Csvt2C |
|---|---|
| InChI | InChI=1S/C25H36N4O4/c1-14(30)23-26-27-28-29(23)13-16-11-21-19-6-5-17-12-18(33-15(2)31)7-9-24(17,3)20(19)8-10-25(21,4)22(16)32/h5,16,18-22,32H,6-13H2,1-4H3/t16-,18+,19-,20+,21+,22+,24+,25+/m1/s1 |
| InChIKey | UDCZDPSKFSDVJG-VVKIPQOKSA-N |
| Mol Weight | 456.6 g/mol |
| Molecular Formula | C25H36N4O4 |
| Exact Mass | 456.273656 g/mol |
| Enantiomer InChIKey | UDCZDPSKFSDVJG-ONNFJOIRSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
3-BETA-ACETOXY-16-BETA-[4-(4-FLUOROPHENYL)-1H-1,2,3-TRIAZOL-1-YLMETHYL]-ANDROST-5-EN-17-BETA-OL
3-BETA-ACETOXY-16-BETA-[4-(3-TOLYL)-1H-1,2,3-TRIAZOL-1-YLMETHYL]-ANDROST-5-EN-17-BETA-OL
3-BETA-ACETOXY-16-BETA-(4-CYCLOPROPYL-1H-1,2,3-TRIAZOL-1-YLMETHYL)-ANDROST-5-EN-17-BETA-OL
3-BETA-ACETOXY-16-BETA-[4-(4-TERT.-BUTYLPHENYL)-1H-1,2,3-TRIAZOL-1-YLMETHYL]-ANDROST-5-EN-17-BETA-OL
3-BETA-ACETOXY-16-BETA-(4-PHENYL-1H-1,2,3-TRIAZOL-1-YLMETHYL)-ANDROST-5-EN-17-BETA-OL
3-BETA-ACETOXY-16-BETA-[4-(3-AMINOPHENYL)-1H-1,2,3-TRIAZOL-1-YLMETHYL]-ANDROST-5-EN-17-BETA-OL
3-BETA-ACETOXY-16-BETA-[4-(4-ETHYLPHENYL)-1H-1,2,3-TRIAZOL-1-YLMETHYL]-ANDROST-5-EN-17-BETA-OL
(16R) Ethyl 3,16-diacetoxy-20-methyl-24-nor-chol-5-en-23-oate
16-ALPHA-(ACETYLOXYMETHYL)-ANDROST-5-EN-3-BETA-17-BETA-DIOLACETATE
16-BETA-(ACETYLOXYMETHYL)-ANDROST-5-EN-3-BETA-17-ALPHA-DIOL-DIACETATE
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis and In Vitro Antiproliferative Activity of Novel Androst-5-ene Triazolyl and Tetrazolyl Derivatives | Molecules | 2011 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.